(RTTNews) - Akari Therapeutics, Plc (AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced a strategic research collaboration wit…
(RTTNews) - On Tuesday, CVS Health Corp. (CVS) announced avilability of common prescription medications for dogs and cats at its approximately 9000 pharmacy locations across the US.
(RTTNews) - Toy and game company Hasbro, Inc. (HAS) reported Tuesday net earnings attributable to Hasbro for the second quarter of $160.9 million or $1.12 per share, compared to a net loss of $855.8 million or $6.10 per…
(RTTNews) - Novartis AG (NVS) Tuesday reported a relatively lower second quarter income, despite generating a modest increase in net sales, driven by strong growth in its oncology portfolio. The Swiss drugmaker also rea…
(RTTNews) - Agios Pharmaceuticals Inc. (AGIO) a commercial-stage biopharmaceutical company, on Tuesday announced the discontinuation of the Phase 2 trial evaluating Tebapivat for Sickle Cell Disease, as the drug failed …
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from AGD is likely to continue, and whether the current estimated yield of 11.88% o…
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from MIN is likely to continue, and whether the current estimated yield of 9.66% on…
(RTTNews) - Northrop Grumman (NOC) increased its sales and EPS guidance for the year based on the demand for its technologies. For fiscal 2026, the company now expects: MTM-adjusted EPS in a range of $28.60 — $29.10, re…
The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.19%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.59%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.04%. September E-mini S&P futures (ESU2…
(RTTNews) - Positron Corporation (POSC), a medical technology company, on Monday reported receiving three orders for the company's 64-slice PET/CT scan machines through multi-year agreements for use in cardiological dia…
Last week was a rough one for International Business Machines (NYSE: IBM) as the company's preannounced results rattled the stock, and that's putting it lightly. Shares cratered, and fears mounted about the business's f…
The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.19%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.59%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.04%. September E-mini S&P futures (ESU2…
The dollar index (DXY00) rose by +0.18% on Monday. The dollar strengthened on Monday as escalation of hostilities between the US and Iran is boosting crude oil prices, which raises inflation expectations that could prom…
(RTTNews) - Roche Holding AG (RO.SW) announced the appointment of Dan Malarek as President and Chief Executive Officer of Roche Diagnostics North America, effective August 1, 2026. He succeeds Brad Moore, who will retir…
(RTTNews) - Alfa Laval AB (ALFA.ST) reported that its second quarter net income was 2.04 billion Swedish kronor, compared to 2.03 billion kronor in the prior year period. Earnings per share increased to 4.91 kronor from…
The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.19%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.59%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.04%. September E-mini S&P futures (ESU2…
(RTTNews) - Telix Pharmaceuticals Limited (TLX), a radiopharmaceutical company, reported a rise in revenue for the second quarter, helped by the increased revenue from the precision medicine business.
(RTTNews) - Asian stocks ended mixed on Tuesday as chip stocks rebounded from recent declines, helping offset concerns over a return of armed hostilities in the Middle East.
(RTTNews) - Swatch Group AG (SWGAF, SWGNF, UHRN.SW), a Swiss manufacturer of watches and jewelry, reported Tuesday lower net profit in its first half, but higher profit attributable to shareholders amid increased net sa…
We use cookies to improve your experience and analyse site traffic. By continuing to browse, you agree to our use of cookies.